Title |
Neurodegeneration as a consequence of failed mitochondrial maintenance
|
---|---|
Published in |
Acta Neuropathologica, December 2011
|
DOI | 10.1007/s00401-011-0921-0 |
Pubmed ID | |
Authors |
Mariusz Karbowski, Albert Neutzner |
Abstract |
Maintaining the functional integrity of mitochondria is pivotal for cellular survival. It appears that neuronal homeostasis depends on high-fidelity mitochondria, in particular. Consequently, mitochondrial dysfunction is a fundamental problem associated with a significant number of neurological diseases, including Parkinson's disease (PD), Huntington's disease (HD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and various peripheral neuropathies, as well as the normal aging process. To ensure optimal mitochondrial function, diverse, evolutionarily conserved mitochondrial quality control mechanisms are in place, including the scavenging of toxic reactive oxygen species (ROS) and degradation of damaged mitochondrial proteins, but also turnover of whole organelles. In this review we will discuss various mitochondria-associated conditions, focusing on the role of protein turnover in mitochondrial maintenance with special emphasis on neurodegenerative disorders. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 1 | <1% |
South Africa | 1 | <1% |
United Kingdom | 1 | <1% |
Japan | 1 | <1% |
United States | 1 | <1% |
Unknown | 183 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 41 | 22% |
Student > Ph. D. Student | 38 | 20% |
Student > Master | 26 | 14% |
Student > Bachelor | 18 | 10% |
Student > Doctoral Student | 8 | 4% |
Other | 26 | 14% |
Unknown | 31 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 64 | 34% |
Biochemistry, Genetics and Molecular Biology | 27 | 14% |
Medicine and Dentistry | 25 | 13% |
Neuroscience | 14 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 4% |
Other | 17 | 9% |
Unknown | 34 | 18% |